Asensus Surgical Performance

The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Asensus Surgical are completely uncorrelated.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Asensus Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Asensus Surgical is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Quick Ratio1.80
Fifty Two Week Low0.2800
Target High Price1.45
Fifty Two Week High6.9500
Target Low Price1.45
  

Asensus Surgical Relative Risk vs. Return Landscape

If you would invest (100.00) in Asensus Surgical on January 20, 2024 and sell it today you would earn a total of  100.00  from holding Asensus Surgical or generate -100.0% return on investment over 90 days. Asensus Surgical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Asensus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Asensus Surgical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Asensus Surgical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Asensus Surgical, and traders can use it to determine the average amount a Asensus Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
TRXC
Based on monthly moving average Asensus Surgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Asensus Surgical by adding Asensus Surgical to a well-diversified portfolio.

Asensus Surgical Fundamentals Growth

Asensus Stock prices reflect investors' perceptions of the future prospects and financial health of Asensus Surgical, and Asensus Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Asensus Stock performance.

Things to note about Asensus Surgical performance evaluation

Checking the ongoing alerts about Asensus Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Asensus Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Asensus Surgical is not yet fully synchronised with the market data
Asensus Surgical has some characteristics of a very speculative penny stock
Asensus Surgical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 2.75 M. Net Loss for the year was (59.96 M) with loss before overhead, payroll, taxes, and interest of (4.79 M).
Asensus Surgical currently holds about 19.96 M in cash with (48.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Evaluating Asensus Surgical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Asensus Surgical's stock performance include:
  • Analyzing Asensus Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Asensus Surgical's stock is overvalued or undervalued compared to its peers.
  • Examining Asensus Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Asensus Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Asensus Surgical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Asensus Surgical's stock. These opinions can provide insight into Asensus Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Asensus Surgical's stock performance is not an exact science, and many factors can impact Asensus Surgical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Asensus Stock

If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements